5 hours Should You Continue to Hold Bio-Rad Stock in Your Portfolio? Zacks
BIO strategically expands its ddPCR platform while eyeing global expansion and benefiting from its clinical diagnostics arm.
BIO strategically expands its ddPCR platform while eyeing global expansion and benefiting from its clinical diagnostics arm.